Diagnos Laboratorium Utama Tbk. vs Repower Asia Indonesia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Repower Asia Indonesia Tbk. trades at Rp50 (market cap 331.68B, 85.51M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. and Repower Asia Indonesia Tbk. are close in size by market cap, and Repower Asia Indonesia Tbk. is more actively traded (85.51M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | REAL | |
|---|---|---|
Market Cap | 310.75B | 331.68B |
Volume | 963.6K | 85.51M |
Lot | 9.64K | 855.15K |
Turnover | 217.67M | 4.31B |
Average Price | 225.89 | 50.45 |
Value | 217.67M | 4.31B |
Indicative Equilibrium Price | 226 | 50 |
Indicative Equilibrium Volume | 1K | 118 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Repower Asia Indonesia Tbk (the Company) was established based on Notarial Deed No. 04 of Titik Krisna Murti Wikaningsih, S.H., M.KN., dated March 13, 2011, a Notary in Bekasi.
Read more on REAL →